山东癫痫病医院口碑山东治疗儿童医院癫痫专病,潍坊癫痫治疗新技术,河南治疗癫痫医院好的是,聊城癫痫病医院预约,聊城看癫痫好专科医院,聊城治疗羊癫疯病一般需费用,全国治癫痫病效果好的医院

CANBERRA, Sept. 7 (Xinhua) -- A team of Australian and U.S. scientists on Wednesday said they discovered a genetic defect, which can lead to Leigh syndrome, a rare disorder which affects the central nervous syndrome.The scientists tested more than 1000 genes by encoding proteins active in two individuals who suffer from the illness. They used a new technique known as next-generation DNA sequencing to examine the genes.The gene they discovered encodes an enzyme which is found in the mitochondria which are subsets of cells. Without this enzyme the mitochondria do not translate proteins efficiently, and this then causes Leigh syndrome.According to David Thorburn, from the Murdoch Children's Research Institute in Melbourne, the discovery shows the enormous potential of the new technology."These findings demonstrate the ability of sequencing technologies to improve diagnosis," Professor Thorburn said in a statement released on Wednesday."Although it isn't clear in the case of Leigh syndrome whether the precise molecular diagnosis will necessarily lead to therapies, the current findings represent a meaningful service."He added that diagnosis of the disease along with its specific genetic cause can also be informative about the risk a couple has of having another affected child. The diagnostic information can help in decisions about whether and how to pursue alternative means of having children, for instance through the use of donor sperm or eggs.The research team consisted of scientists from Australia's Murdoch Institute as well as the Broad Institute in the U.S.In Leigh syndrome, infants are born apparently healthy only to develop movement and breathing disorders that worsen over time, often leading to death by the age of three. The problem is that the mitochondria responsible for powering their cells cannot keep up with the demand for energy in their developing brains.

BERLIN, July 26 (Xinhua) -- German national disease control center said on Tuesday that the country's deadly E. coli outbreak has been over, as no new case reported in the last three weeks.The Robert Koch Institute (RKI) said the last case related to the E.coli outbreak was reported on July 4.As a three-week-period would cover the disease's incubation time, diagnosis time and the time for the transfer of a case, this virtually means an end of the outbreak."The largest EHEC outbreak is over in Germany," said RKI President Reinhard Burger. "I pay tribute to people who have joined in the great work, making investigation and looking after the patients."The RKI said Germany would keep watching the deadly EHEC O104: H4 intensively and asked people to pay attention to personal and food hygiene, as individual infection still cannot be ruled out.This round of outbreak has claimed 52 lives and affected more than 4,000 people since early May.The source of this disease was first believed to be cucumbers and tomatoes from Spain, and then was locked onto bean sprouts grown in a farm near Hamburg in the state Lower Saxony. Later European authorities said one batch of fenugreek seeds from Egypt was probably the source.

BEIJING, June 7 (Xinhuanet) -- Sony Corp. on Monday unveiled its next generation portable gaming device, PlayStation Vita.The new PlayStation Vita will go on sale for 249 U.S. dollars, or 299 dollars for a 3G mobile version, starting in the holiday season, the Japanese electronics giant's No. 2 executive Kazuo Hirai told reporters on the eve of the E3 games convention.The device will allow gamers to be connected with one another over cellphone networks and Wi-Fi hotspots, and use GPS location-tracking technology. In the U.S., Sony is partnering exclusively with AT&T Inc. for cellphone service.Company executives have called the device Sony's biggest product launch since the PlayStation 3 five years ago."PlayStation Vita will revolutionize the portable entertainment experience," said Hirai. "The whole world is really in play."The handheld has front and back cameras, a touchscreen in front, a touch pad on the back and two knob-like joysticks. It will enable gamers to play against people using PlayStation 3 consoles over the Internet-based PlayStation Network.

WASHINGTON, Sept. 14 (Xinhua) -- Controlling diabetes may someday involve mining stem cells from the lining of the uterus, Yale School of Medicine researchers report in a new study published Wednesday in the journal Molecular Therapy. The team treated diabetes in mice by converting cells from the uterine lining into insulin-producing cells.The endometrium or uterine lining, is a source of adult stem cells. These cells generate uterine tissue each month as part of the menstrual cycle. Like other stem cells, however, they can divide to form other kinds of cells.Led by Yale Professor Hugh Taylor, the researchers bathed endometrial stem cells in cultures containing special nutrients and growth factors. Responding to these substances, the endometrial stem cells adopted the characteristics of beta cells in the pancreas that produce insulin. Over the course of a three- week incubation process, the endometrial stem cells took on the shape of beta cells and began to make proteins typically made by beta cells. Some of these cells also produced insulin.After a meal, the body breaks food down into components like the sugar glucose, which then circulates in the blood. In response, beta cells release insulin, which allows the body's cells to take in the circulating glucose. In this study, Taylor and his team exposed the mature stem cells to glucose and found that, like typical beta cells, the cultured cells responded by producing insulin. The team then injected diabetic mice with the mature, insulin-making stem cells. The mice had few working beta cells and very high levels of blood glucose.Mice that did not receive the stem cell therapy continued having high blood sugar levels, developed cataracts and were lethargic. In contrast, mice that received the cell therapy were active and did not develop cataracts, but the animals' blood sugar levels remained higher than normal.The Yale team's findings suggest that endometrial stem cells could be used to develop insulin-producing islet cells, which are found in the pancreas. These islet cells could then be used to advance the study of islet cell transplantation to treat people with diabetes.Taylor said in a statement that the next step in the research will be to verify how long this treatment remains effective.